Investor Relations
Bursa Announcements
Media News
Corporate Videos
Corporate Audios
Corporate Calendar
Bursa Announcements
Stock Name / Code :
PHARMA ( 7081 )
Year :
2026
2025
2024
2023
2022
Archives
Select Date Range :
Categories :
Category
Additional Listing Announcement
Annual Audited Accounts
Annual Reports
Change of Corporate Information
Changes in Shareholdings
Circulars/Notice to Shareholders
Dealings in Listed Securities (Chapter 14 of Listing Requirements)
Delisting of Securities
Disclosure On Quarterly Production
Entitlements
Expiry / Maturity / Termination of Securities
Financial Results
General Announcement
General Meetings
Important Relevant Dates for Renounceable Rights
Investor Alert
IPO Announcement/LEAP Market Announcement
Listing Circulars
Listing Information and Profile
Prospectus
Reply to Query
Shares Buy Back
Special Announcements
Take-over Offer
Transfer of Listing
Unusual Market Activity
Filter
Reset
Thursday - 28 May 2026
OTHERS
SURAT SETUJU TERIMA (HEREINAFTER REFERRED TO AS THE "SST") FOR THE SUPPLY OF RECOMBINANT HUMAN INSULIN 110 IU/ML PENFILL/REFILL ON A PACKAGE BASIS (HEREINAFTER REFERRED TO AS "THE PRODUCTS") BETWEEN PHARMANIAGA LIFESCIENCE SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF PHARMANIAGA BERHAD AND GOVERMENT OF MALAYSIA.
Thursday - 21 May 2026
PHARMA - Notice of Book Closure
Wednesday - 20 May 2026
Share Consolidation
Tuesday - 19 May 2026
GENERAL MEETINGS: Outcome of Meeting
GENERAL MEETINGS: Outcome of Meeting
PHARMA - Notice of Book Closure
Monday - 18 May 2026
Interim Dividend
Quarterly rpt on consolidated results for the financial period ended 31 Mar 2026
Monday - 27 Apr 2026
CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIAGA BERHAD ("PHARMANIAGA SHARE(S)") INTO 1 PHARMANIAGA SHARE HELD ON AN ENTITLEMENT DATE TO BE DETERMINED LATER ("PROPOSED SHARE CONSOLIDATION")
Friday - 24 Apr 2026
GENERAL MEETINGS: Notice of Meeting
Friday - 17 Apr 2026
Annual Report & CG Report - 2025
CIRCULAR TO SHAREHOLDERS IN RELATION TO THE PROPOSED RENEWAL OF SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS OF A REVENUE OR TRADING NATURE
Thursday - 16 Apr 2026
GENERAL MEETINGS: Notice of Meeting
Tuesday - 14 Apr 2026
SUBDIVISION / CONSOLIDATION OF SHARES (CHAPTER 13 OF LISTING REQUIREMENTS)
PHARMANIAGA BERHAD ("PHARMANIAGA" OR THE "COMPANY") PROPOSED CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIAGA ("PHARMANIAGA SHARE(S)") OR "SHARE(S)") INTO 1 PHARMANIAGA SHARE ("CONSOLIDATED SHARE(S)") ("PROPOSED SHARE CONSOLIDATION")
Wednesday - 8 Apr 2026
SUBDIVISION / CONSOLIDATION OF SHARES (CHAPTER 13 OF LISTING REQUIREMENTS)
PHARMANIAGA BERHAD ("PHARMANIAGA" OR THE "COMPANY") PROPOSED CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIAGA ("PHARMANIAGA SHARE(S)") OR "SHARE(S)") INTO 1 PHARMANIAGA SHARE ("CONSOLIDATED SHARE(S)") ("PROPOSED SHARE CONSOLIDATION")
«
1
2
3
4
5
6
7
8
9
10
»